Following an evaluation of extensive scientific evidence, Health Canada approved the following NPN (Natural Product Number) claims for SEBiotic : Helps to relieve symptoms of irritable bowel syndrome (IBS), such as abdominal pain, bloating, cramping and nausea Helps support a healthy gut flora Source of probiotics Supports the maintenance of digestive health This combination of clinical evidence and regulatory trust makes SEBiotic a standout for brands aiming to support GLP-1 users
Safety of sodium-glucose co-transporter 2 inhibitors
Da-Cheng-Qi decoction improves severe acute pancreatitis-associated acute lung injury by interfering with intestinal lymphatic pathway and reducing HMGB1-induced inflammatory response in rats
I realize not everyone has time to read a series like that, and a podcast is a good way to get basic ideas across and just another way for the information to sink in
Novo Nordisk A/S, Eli Lilly and Company, Sanofi, AstraZeneca, GSK, Regeneron Pharmaceuticals Inc., Pfizer Inc., Amgen Inc., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, ZEALAND PHARMA, Hanmi Pharm